| | COMPOUND: C07949 | |
Entry |
|
Name |
|
Formula |
C14H11NO5
|
Exact mass |
273.0637
|
Mol weight |
273.24
|
Structure |
|
Remark |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N04 ANTI-PARKINSON DRUGS
N04B DOPAMINERGIC AGENTS
N04BX Other dopaminergic agents
N04BX01 Tolcapone
D00786 Tolcapone (JAN/USP/INN) <US>
USP drug classification [BR:br08302]
Antiparkinson Agents
Antiparkinson Agents, Other
Tolcapone
D00786 Tolcapone (JAN/USP/INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01497 Catechol O-methyltransferase inhibitor
D00786 Tolcapone
DG01967 Antiparkinson agent
DG02909 COMT inhibitor
D00786 Tolcapone
Drug classes [BR:br08332]
Neuropsychiatric agent
DG01967 Antiparkinson agent
D00786 Tolcapone
Target-based classification of drugs [BR:br08310]
Enzymes
Transferases (EC2)
Methyltransferases
COMT
D00786 Tolcapone (JAN/USP/INN) <US>
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D00786
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D00786
|
Other DBs |
|
KCF data |
ATOM 20
1 C8x C 20.6536 -17.2235
2 C8y C 20.6536 -18.6241
3 C8x C 21.8664 -19.3243
4 C8x C 23.0794 -18.6241
5 C8y C 23.0794 -17.2235
6 C8x C 21.8664 -16.5233
7 C8x C 25.5051 -18.6241
8 C8y C 25.5051 -17.2235
9 C5a C 24.2922 -16.5233
10 C8y C 26.7180 -19.3243
11 C8y C 27.9308 -18.6241
12 C8y C 27.9308 -17.2235
13 C8x C 26.7180 -16.5233
14 C1a C 19.4408 -19.3243
15 O5a O 24.2922 -15.1228
16 O1a O 26.7180 -20.7245
17 O1a O 29.1478 -19.3266
18 N2b N 29.1478 -16.5210 #+
19 O3a O 30.3457 -17.2127 #-
20 O3a O 29.1478 -15.1230
BOND 21
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 7 8 1
8 8 9 1
9 5 9 1
10 7 10 2
11 10 11 1
12 11 12 2
13 12 13 1
14 8 13 2
15 2 14 1
16 9 15 2
17 10 16 1
18 11 17 1
19 12 18 1
20 18 19 1
21 18 20 2
|
|
» Japanese version
|
|